Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL Weiner, JA Cohen - Multiple Sclerosis Journal, 2002 - journals.sagepub.com
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …
被引用次数：197 相关文章

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL Weiner, JA Cohen - Multiple Sclerosis Journal, 2002 - search.proquest.com
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.

HL Weiner, JA Cohen - Multiple Sclerosis (Houndmills, Basingstoke …, 2002 - europepmc.org
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL Weiner, JA Cohen - Multiple Sclerosis Journal, 2002 - cir.nii.ac.jp
抄録< jats: p> Cyclophosphamide is an alkylating agent used to treat malignancies and
immune-mediated inflammatory non-malignant processes such as lupus nephritis and …

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.

HL Weiner, JA Cohen - Multiple Sclerosis (13524585), 2002 - search.ebscohost.com
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL Weiner, JA Cohen - Multiple sclerosis (Houndmills …, 2002 - pubmed.ncbi.nlm.nih.gov
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …

[引用][C] Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL WEINER, JA COHEN - Multiple sclerosis, 2002 - pascal-francis.inist.fr
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and
immunologic effects CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effectsy

HL Weiner, JA Cohen - Multiple Sclerosis, 2002 - search.ebscohost.com
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated
inflammatory non-malignant processes such as lupus nephritis and immune-mediated …

[引用][C] Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

HL WEINER, JA COHEN - Multiple sclerosis, 2002 - Sage Publications